1 enrolling by invitation. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Sickle Cell Disease: new trials by email Literature Review of Sickle Cell Disease trials Research Report on Sickle Cell Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The BENeFiTS Trial in Beta Thalassemia Intermedia Benserazide Only Product - Beta Thalassemia Intermedia, Sickle Cell Disease | Phase 1 / Phase 2 | Enrolling by invitation | Phoenicia BioScience | 36 | 2020-10-05 | 2025-08-15 |
Anemia, Sickle Cell (1) · beta-Thalassemia (1)
Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemoglobinopathies (1) · Thalassemia (1)
Canada (1) · United States (1)
Hanny D Al-Samkari, MD (1) · Kevin Kuo, MD (1) · Sujit Sheth, MD MS (1) · Susan Perrine, MD (1) · Sylvia Singer, MD (1)
R33HL147845 (1)